USGIU
BEAT

U.S. Global Investors (USGI)’s BioTelemetry, Inc. BEAT Stock Holding History

U.S. Global Investors (USGI)’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,335
Closed -$788K – 193
2019
Q3 		$788K Buy
+19,335
New +$835K 0.43% 73

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

U.S. Global Investors (USGI)'s BEAT Position: Q4 2019 in Review

U.S. Global Investors (USGI) sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 19,335 shares — an estimated $788K sold.

U.S. Global Investors (USGI) first reported a position in BEAT in Q3 2019 and held it in 1 quarter. The position peaked at $788K in Q3 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

  • U.S. Global Investors (USGI) reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
  • U.S. Global Investors (USGI) sold 19,335 BioTelemetry, Inc. shares in Q4 2019, an estimated $788K.
  • U.S. Global Investors (USGI) first reported a position in BioTelemetry, Inc. in Q3 2019 and held it in 1 quarter.
  • U.S. Global Investors (USGI)'s BioTelemetry, Inc. position peaked at $788K in Q3 2019.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on U.S. Global Investors (USGI)'s 13F filing for Q4 2019, filed 12 Feb 2020.